Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer

Breast Cancer Research and Treatment

Volumn 105, Issue 1, 2007, Pages 63-68

  Van Den Broek, N ^a   Van Der Sangen, M J C ^b   Van De Poll Franse, L V ^c   Van Beek, M W P M ^d   Nieuwenhuijzen, G A P ^b   Voogd, A C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

^c Eindhoven Cancer Registry   (Netherlands)

^d Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

Author keywords

Breast carcinoma; Breast conserving surgery; Lobular; Local; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER REGISTRY; CANCER RISK; CANCER SIZE; CANCER SURGERY; CONFIDENCE INTERVAL; CONTROLLED STUDY; EXCISION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT CANCER; REOPERATION; RISK ASSESSMENT; UNIVARIATE ANALYSIS;

AGE FACTORS; AGED; BREAST; BREAST NEOPLASMS; CARCINOMA, LOBULAR; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548044225     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9431-5     Document Type: Article

References (25)

1. The World Health Organization Histological Typing of Breast Tumors-Second Edition (1982) The World Organization. Am J Clin Pathol 78(6):806-816
2. Wellings SR, Jensen HM, Marcum RG (1975) An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55(2):231-273
3. Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC (1975) The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer 36(1):1-85
4. Martinez V, Azzopardi JG (1979) Invasive lobular carcinoma of the breast: incidence and variants. Histopathology. 3(6):467-488
5. Verkooijen HM, Fioretta G, Vlastos G et al. (2003) Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland. Int J Cancer 104(6):778-81
6. Li CI, Anderson BO, Daling JR, Moe RE (2003) Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289(11):1421-1424
7. Sastre-Garau X, Jouve M, Asselain B, et al. (1996) Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 77(1):113-120
8. Yeatman TJ, Cantor AB, Smith TJ et al. (1995) Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg 222(4):549-559; discussion. 559-561
9. Silverstein MJ, Lewinsky BS, Waisman JR, Gierson ED, Colburn WJ, Senofsky GM et al. (1994) Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer. 73(6):1673-1677
10. Moore MM, Borossa G, Imbrie JZ et al. (2000) Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. Ann Surg 231(6):877-882
11. Peiro G, Bornstein BA, Connolly JL (2000) The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat 59(1):49-54
12. Chung MA, Cole B, Wanebo HJ, Bland KI, Chang HR (1997) Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol 4(7):545-550
13. Singletary SE, Patel-Parekh L, Bland KI (2005) Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base. Ann Surg 242(2):281-289
14. Holland PA, Shah A, Howell A, Baildam AD, Bundred NJ (1995) Lobular carcinoma of the breast can be managed by breast-conserving therapy. Br J Surg 82(10):1364-1366
15. Bouvet M, Ollila DW, Hunt KK, Babiera GV et al. (1997) Role of conservation therapy for invasive lobular carcinoma of the breast. Ann Surg Oncol 4(8):650-654
16. Kurtz JM, Jacquemier J, Torhorst J et al. (1989) Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer 63(8):1630-1635
17. Schnitt SJ, Connolly JL, Recht A, Silver B, Harris JR (1989) Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer 64(2):448-454
18. Poen JC, Tran L, Juillard G et al. (1992) Conservation therapy for invasive lobular carcinoma of the breast. Cancer 69(11):2789-2795
19. Salvadori B, Biganzoli E, Veronesi P, Saccozzi R, Rilke F (1997) Conservative surgery for infiltrating lobular breast carcinoma. Br J Surg 84(1):106-109
20. White JR, Gustafson GS, Wimbish K et al. (1994) Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast. The role of preoperative mammograms in guiding treatment. Cancer 74(2):640-647
21. Mai KT, Yazdi HM, Isotalo PA (2000) Resection margin status in lumpectomy specimens of infiltrating lobular carcinoma. Breast Cancer Res Treat 60(1):29-33
22. Morrow M, Keeney K, Scholtens D, Wei J, Steel J, Khan SA (2006) Selecting patients for breast-conserving therapy: the importance of lobular histology. Cancer 106(12):2563-2568
23. Newman LA, Kuerer HM (2005) Advances in breast conservation therapy. J Clin Oncol 23(8):1685-1697
24. Voogd AC, Nielsen M, Peterse JL et al. (2001) Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol1.9(6):1688-1697
25. Rutgers EJ, Nortier JW, Tuut MK et al. (2002) [Dutch Institute for Healthcare Improvement guideline, "Treatment of breast cancer"]. Ned Tijdschr Geneeskd 146(45):2144-2151